Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Cantor Fitzgerald
Merck
QuintilesIMS
Daiichi Sankyo
Argus Health
Harvard Business School
Medtronic
AstraZeneca

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018746

« Back to Dashboard

NDA 018746 describes VASOCON-A, which is a drug marketed by Novartis and is included in one NDA. Additional details are available on the VASOCON-A profile page.

The generic ingredient in VASOCON-A is antazoline phosphate; naphazoline hydrochloride. Additional details are available on the antazoline phosphate; naphazoline hydrochloride profile page.
Summary for 018746
Tradename:VASOCON-A
Applicant:Novartis
Ingredient:antazoline phosphate; naphazoline hydrochloride
Patents:0
Formulation / Manufacturing:see details

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION/DROPS;OPHTHALMICStrength0.5%;0.05%
Approval Date:Jul 11, 1994TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Cerilliant
US Army
Cantor Fitzgerald
Accenture
Argus Health
Covington
Express Scripts
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.